Identification of AFAP1L1 as a prognostic marker for spindle cell sarcomas

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Spindle cell sarcomas are heterogeneous tumors where distant metastasis signifies a poor prognosis.
• Current histopathological analyses have limitations in predicting metastatic potential.
• Identifying reliable prognostic markers is crucial for improving patient outcomes.

Purpose of the Study:

• To identify a novel biomarker for predicting distant metastasis in spindle cell sarcomas.
• To investigate the role of actin filament-associated protein 1-like 1 (AFAP1L1) in sarcoma progression and metastasis.

Main Methods:

• Gene expression profiling of 65 spindle cell sarcomas to identify candidate markers.
• Multivariate analysis and quantitative mRNA expression analysis to validate AFAP1L1 as a predictor.
• Immunohistochemical staining on paraffin-embedded tissues to correlate AFAP1L1 expression with metastasis-free rates.
• In vitro experiments involving gene knockdown and forced expression of AFAP1L1 in sarcoma and stem cells.
• In vivo studies assessing tumor growth in AFAP1L1-transduced cell lines.

Main Results:

• AFAP1L1 was identified as a significant independent predictor of distant metastasis in spindle cell sarcomas (P=0.0001).
• Tumors negative for AFAP1L1 showed a significantly better metastasis-free rate (P=0.0093).
• Knocking down AFAP1L1 inhibited sarcoma cell invasion; forced expression induced anchorage-independent growth and increased invasiveness.
• AFAP1L1 overexpression enhanced tumor growth in vivo.

Conclusions:

• AFAP1L1 plays a critical role in the progression and metastatic potential of spindle cell sarcomas.
• AFAP1L1 serves as a valuable prognostic biomarker for predicting distant metastasis in these tumors.
• Targeting AFAP1L1 may offer therapeutic strategies to inhibit sarcoma progression.